← Back to headlines
MiMedx Outlines 2027 Revenue Targets Exceeding $400M Post-Sanara Deal
MiMedx has projected its 2027 revenue to be well over $400 million with an adjusted EBITDA margin exceeding 20%, following its planned deal with Sanara.
30 Jul, 04:34 — 30 Jul, 04:34
Sources
Showing 1 of 1 sources
Related Stories
Shein Shares Plunge on Hong Kong Stock Exchange Debut Amid Growth Concerns
19m ago
South Korea Reports Record August Export Surge Driven by Semiconductor Demand
21m ago
South Korean and Turkish Defense Firms Climb Global Industry Rankings
24m ago
Apple Accuses OpenAI of Misusing Confidential Data and Spoliating Evidence
29m ago